A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

NCT00526812 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen